Article
Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy).
Journal for immunotherapy of cancer - 11 Jul 2018
Ascierto Paolo A, Brugarolas James, Buonaguro Luigi, Butterfield Lisa H, Carbone David, Daniele Bruno, Ferris Robert, Fox Bernard A, Galon Jérôme, Gridelli Cesare, Kaufman Howard L, Klebanoff Christopher A, Melero Ignacio, Nathan Paul, Paulos Chrystal M, Ruella Marco, Sullivan Ryan, Zarour Hassane, Puzanov Igor
Abstract excerpt
Immunotherapy represents the third important wave in the history of the systemic treatment of cancer after chemotherapy and targeted therapy and is now established as a potent and effective treatment option across several cancer types. The clinical success of anti-cytotoxic T-lymphocyte-associated antigen (CTLA)-4, first, and anti-programmed death (PD)-1/PD-ligand (L)1 agents in melanoma and other cancers a few...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.